How, Why and Where it Hurts—Breaking Down Pain Syndrome Among Nursing Home Patients With Dementia: A Cross-Sectional Analysis of the COSMOS Trial

Background Between 40%-60% of nursing home patients with dementia suffer from chronic and acute pain despite increasing their analgesic drug prescription. Aims Determine the locations intensity association between quality life (QoL) four stratified pain–analgesic groups: (1) pain—analgesics treatment; (2) pain—no analgesics; (3) no (4) analgesics. Design Multicenter, multicomponent cluster randomized controlled Communication, Systematic assessment treatment pain, Medication review, Occupational therapy, Safety - an effectiveness (COSMOS) trial. Participants At baseline, 723 were enrolled; 463 completely evaluated for presence included in cross-sectional analyses. Methods Data collected using following tests: Cognitive function (Mini-Mental-State Evaluation [MMSE]); Quality Life Late stage Dementia (QUALID); Dementia-Specific QoL (QUALIDEM); Mobilization–Observation–Behavior–Intensity–Dementia Pain Scale (MOBID-2); number prescriptions. Analysis covariance (ANCOVA) was used to compare across pain–analgesics groups. Results The majority participants (78%) had moderate-to-severe dementia, female (74%), a mean age 86.7 years. Almost 44% reported clinically significant whereas 69% ?2 locations, especially musculoskeletal system. Some 33.5% receiving analgesics, 10% 27% Patients scores lower (<.001) compared assessments relying on different locations. Conclusion Untreated multi-located is still common dementia. A share without receive Proper regular re-assessment are prerequisites prescribing deprescribing more significantly connected QoL. This must be stressed when evaluating